Fate Therapeutics (FATE) PT Lowered to $71 at Piper Sandler
Tweet
Share
E-mailGet Alerts FATE Hot Sheet
Price: $2.72 -0.73%
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 3
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 3
Join SI Premium – FREE
Piper Sandler analyst Edward A. Tenthoff lowered the price target on Fate Therapeutics (NASDAQ: FATE) to $71.00 (from $113.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Berenberg Downgrades Lanxess AG (LXS:GR) (LNXSF) to Sell
- Fraport AG Frankfurt Airport Services Worldwide (FRA:GR) (FPRUY) PT Lowered to EUR81 at JPMorgan
- Nexans SA (NEX:FP) (NXPRF) PT Raised to EUR188 at Berenberg
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
